{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:10:48Z","timestamp":1785802248196,"version":"3.56.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100004087","name":"Restless Legs Syndrome Foundation","doi-asserted-by":"publisher","award":["2,6,24"],"award-info":[{"award-number":["2,6,24"]}],"id":[{"id":"10.13039\/100004087","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004087","name":"Restless Legs Syndrome Foundation","doi-asserted-by":"publisher","award":["29,30"],"award-info":[{"award-number":["29,30"]}],"id":[{"id":"10.13039\/100004087","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012261","name":"Federation of Canadian Municipalities","doi-asserted-by":"publisher","award":["11,12"],"award-info":[{"award-number":["11,12"]}],"id":[{"id":"10.13039\/100012261","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012261","name":"Federation of Canadian Municipalities","doi-asserted-by":"publisher","award":["FGF23"],"award-info":[{"award-number":["FGF23"]}],"id":[{"id":"10.13039\/100012261","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012261","name":"Federation of Canadian Municipalities","doi-asserted-by":"publisher","award":["26,27"],"award-info":[{"award-number":["26,27"]}],"id":[{"id":"10.13039\/100012261","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Sleep Medicine"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.sleep.2024.09.017","type":"journal-article","created":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T06:19:19Z","timestamp":1726726759000},"page":"244-253","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Clinical efficacy and safety of IV ferric carboxymaltose in restless legs syndrome: A meta-analysis of 537 patients"],"prefix":"10.1016","volume":"124","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-6646-391X","authenticated-orcid":false,"given":"Syeda Nimra","family":"Qadri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-7408-7098","authenticated-orcid":false,"given":"Saifullah","family":"Jamil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-8455-4514","authenticated-orcid":false,"given":"Subhan","family":"Zahid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-1483-1432","authenticated-orcid":false,"given":"Tehreem","family":"Asghar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-2655-4850","authenticated-orcid":false,"given":"Syeda Muzna","family":"Gillani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-4696-5053","authenticated-orcid":false,"given":"Soban Ali","family":"Qasim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-3898-1795","authenticated-orcid":false,"given":"Tilyan","family":"Kambar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-5987-9910","authenticated-orcid":false,"given":"Zain Ul","family":"Abideen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-4586-8432","authenticated-orcid":false,"given":"Usama","family":"Brohi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-5446-1267","authenticated-orcid":false,"given":"Sammon Khan","family":"Tareen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-6208-0421","authenticated-orcid":false,"given":"Palay Khan","family":"Tareen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandhya","family":"Kumari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satesh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahima","family":"Khatri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.sleep.2024.09.017_bib1","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1111\/1756-185X.14710","article-title":"Restless leg syndrome in rheumatic conditions: its prevalence and risk factors, a meta-analysis","volume":"26","author":"Padhan","year":"2023","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.sleep.2024.09.017_bib2","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.sleep.2021.05.036","article-title":"Randomized, placebo-controlled trial of ferric carboxymaltose in restless legs syndrome patients with iron deficiency anemia","volume":"84","author":"Bae","year":"2021","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2024.09.017_bib3","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.sleep.2023.06.023","article-title":"Ferric carboxymaltose effects on restless legs syndrome and on brain iron in patients with iron deficiency anemia","volume":"109","author":"Bae","year":"2023","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2024.09.017_bib4","doi-asserted-by":"crossref","first-page":"1473e6","DOI":"10.1016\/j.sleep.2014.08.012","article-title":"Response to intravenous iron in patients with iron deficiency anemia (IDA) and restless leg syndrome (Wil- liseEkbom disease)","volume":"15","author":"Mehmood","year":"2014","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2024.09.017_bib5","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.sleep.2019.01.040","article-title":"Efficacy and tolerability of intravenous iron for patients with restless legs syndrome: evidence from randomized trials and observational studies","volume":"61","author":"Yang","year":"2019","journal-title":"Sleep Med"},{"issue":"9","key":"10.1016\/j.sleep.2024.09.017_bib6","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.sleep.2011.06.009","article-title":"Clinical efficacy and safety of IV ferric carboxymaltose (IV FCM) treatment of RLS: a multi-centred, placebo- controlled preliminary clinical trial","volume":"12","author":"Allen","year":"2011","journal-title":"Sleep Med"},{"issue":"6","key":"10.1016\/j.sleep.2024.09.017_bib7","doi-asserted-by":"crossref","first-page":"739","DOI":"10.2165\/00003495-200969060-00007","article-title":"Ferric carboxymaltose: a review of its use in iron-deficiency anaemia","volume":"69","author":"Lyseng-Williamson","year":"2009","journal-title":"Drugs"},{"key":"10.1016\/j.sleep.2024.09.017_bib8","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.sleep.2023.10.022","article-title":"Association of low serum ferritin levels with augmentation in patients with restless legs syndrome: a systematic review and meta-analysis","volume":"112","author":"Li","year":"2023","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2024.09.017_bib9","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.sleep.2016.06.003","article-title":"Connectome, and molecular pharmacological differences in the dopaminergic system in restless legs syndrome (RLS): plastic changes and neuroadaptations that may contribute to augmentation","volume":"31","author":"Earley","year":"2017","journal-title":"Sleep Med"},{"issue":"12","key":"10.1016\/j.sleep.2024.09.017_bib10","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1002\/mds.20257","article-title":"TREAT RLS 2 (Therapy with Ropinirole: efficacy and Tolerability in RLS 2) Study Group. Ropinirole is effective in the treatment of restless legs syndrome. TREAT RLS 2: a 12-week, double-blind, randomized, parallel-group, placebo-controlled study","volume":"19","author":"Walters","year":"2004","journal-title":"Mov Disord"},{"issue":"2","key":"10.1016\/j.sleep.2024.09.017_bib11","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1172\/JCI106228","article-title":"Ferrokinetics: a biologic model for plasma iron exchange in man","volume":"49","author":"Cook","year":"1970","journal-title":"J Clin Invest"},{"issue":"25","key":"10.1016\/j.sleep.2024.09.017_bib12","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1056\/NEJM198206243062504","article-title":"Perspectives in iron metabolism","volume":"306","author":"Finch","year":"1982","journal-title":"N Engl J Med"},{"key":"10.1016\/j.sleep.2024.09.017_bib13","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1080\/00365518409083610","article-title":"A comparison between serum ferritin concentration and the amount of bone marrow stainable iron","volume":"44","author":"Harju","year":"1984","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1016\/j.sleep.2024.09.017_bib14","first-page":"1628","article-title":"A controlled study of the effects of ferric carboxymaltose on bone and haematinic biomarkers in chronic kidney disease and pregnancy","volume":"33","author":"Huang","year":"2018","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.sleep.2024.09.017_bib15","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.sleep.2024.09.017_bib16","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S1389-9457(02)00193-4","article-title":"Factor analysis of the international restless legs syndrome study group's scale for restless legs severity","volume":"4","author":"Allen","year":"2003","journal-title":"Sleep Med"},{"issue":"6","key":"10.1016\/j.sleep.2024.09.017_bib17","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection","volume":"30","author":"Ware","year":"1992","journal-title":"Med Care"},{"issue":"1","key":"10.1016\/j.sleep.2024.09.017_bib18","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s40629-016-0006-7","volume":"26","author":"Klimek","year":"2017","journal-title":"Allergo J Int"},{"issue":"2","key":"10.1016\/j.sleep.2024.09.017_bib19","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1524-4733.2005.03010.x","article-title":"Validation of the restless legs syndrome quality of life questionnaire","volume":"8","author":"Abetz","year":"2005","journal-title":"Value Health"},{"key":"10.1016\/j.sleep.2024.09.017_bib20","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomized trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.sleep.2024.09.017_bib21","article-title":"Clinical efficacy and safety of intravenous ferric carboxymaltose for treatment of restless legs syndrome: a multicenter, randomized, placebo-controlled clinical trial","volume":"16","author":"Earley","year":"2024","journal-title":"Sleep"},{"issue":"10","key":"10.1016\/j.sleep.2024.09.017_bib22","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1002\/mds.27040","article-title":"Ferric carboxymaltose in patients with restless legs syndrome and nonanemic iron deficiency: a randomized trial","volume":"32","author":"Trenkwalder","year":"2017","journal-title":"Mov Disord"},{"key":"10.1016\/j.sleep.2024.09.017_bib23","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.sleep.2017.11.1134","article-title":"Efficacy of ferric carboxymaltose (FCM) 500 mg dose for the treatment of Restless Legs Syndrome","volume":"42","author":"Cho","year":"2018","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2024.09.017_bib24","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.sleep.2016.06.021","article-title":"Clinical efficacy of ferric carboxymaltose treatment in patients with restless legs syndrome","volume":"25","author":"Cho","year":"2016","journal-title":"Sleep Med"},{"issue":"4","key":"10.1016\/j.sleep.2024.09.017_bib25","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1007\/s11325-021-02311-5","article-title":"Prevalence of restless leg syndrome and effects on quality of life during pregnancy","volume":"25","author":"Tuna","year":"2021","journal-title":"Sleep Breath"},{"issue":"1","key":"10.1016\/j.sleep.2024.09.017_bib26","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1053\/j.ajkd.2016.07.031","article-title":"Sleep disorders, restless legs syndrome, and uremic pruritus: diagnosis and treatment of common symptoms in dialysis patients","volume":"69","author":"Scherer","year":"2017","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1016\/j.sleep.2024.09.017_bib27","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1186\/s13104-021-05701-w","article-title":"Association of quality of life, anxiety, and depression with restless leg syndrome in the hemodialysis patients","volume":"14","author":"Yaseen","year":"2021","journal-title":"BMC Res Notes"},{"issue":"1","key":"10.1016\/j.sleep.2024.09.017_bib28","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1007\/s13311-021-01019-4","article-title":"Restless legs syndrome: contemporary diagnosis and treatment","volume":"18","author":"Gossard","year":"2021","journal-title":"Neurotherapeutics"},{"issue":"10","key":"10.1016\/j.sleep.2024.09.017_bib29","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1002\/mds.22562","article-title":"A randomized, double-blind, placebo controlled, multi-center study of intravenous iron sucrose and placebo in the treatment of restless legs syndrome","volume":"24","author":"Grote","year":"2009","journal-title":"Mov Disord"},{"issue":"2","key":"10.1016\/j.sleep.2024.09.017_bib30","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.sleep.2007.12.006","article-title":"A randomized, double-blind, placebo-controlled trial of intravenous iron sucrose in restless legs syndrome","volume":"10","author":"Earley","year":"2009","journal-title":"Sleep Med"}],"container-title":["Sleep Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1389945724004386?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1389945724004386?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,25]],"date-time":"2025-01-25T04:17:24Z","timestamp":1737778644000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1389945724004386"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":30,"alternative-id":["S1389945724004386"],"URL":"https:\/\/doi.org\/10.1016\/j.sleep.2024.09.017","relation":{},"ISSN":["1389-9457"],"issn-type":[{"value":"1389-9457","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical efficacy and safety of IV ferric carboxymaltose in restless legs syndrome: A meta-analysis of 537 patients","name":"articletitle","label":"Article Title"},{"value":"Sleep Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sleep.2024.09.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}